RT Book, Section
A1 Rowe, Camille
A1 Sherman, Marian
A2 Freeman, Brian S.
A2 Berger, Jeffrey S.
SR Print(0)
ID 1102569298
T1 Anti-inflammatory Pulmonary Drugs
T2 Anesthesiology Core Review: Part One Basic Exam
YR 2014
FD 2014
PB McGraw-Hill Education
PP New York, NY
SN 9780071821377
LK accessanesthesiology.mhmedical.com/content.aspx?aid=1102569298
RD 2024/04/16
AB Chronic  inflammatory  diseases  of  the  lungs,  including  asthma  and  chronic  obstructive  pulmonary  disease  (COPD),  are  common  pulmonary  causes  of  morbidity  and  mortality.  Although  triggered  by  somewhat  different  mechanisms,  both  result  in  cell-mediated  inflammation  in  the  lungs  (predominantly,  eosinophilic  in  asthma  and  neutrophilic  in  COPD),  leading  to  manifestations  of  increased  bronchial  smooth  muscle  tone,  increased  bronchial  wall  thickness,  excess  secretion  of  mucus,  and  (in  the  case  of  COPD)  loss  of  elasticity  of  lung  parenchyma.  Chronic  inflammatory  disease  patients  experience  the  typical  symptoms  of  cough  and  dyspnea.  Various  medications  are  used  both  singly  and  in  combination  to  reduce  chronic  inflammation,  and  thereby  relieve  symptoms  associated  with  asthma  and  COPD.